NDC11 60492017302
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 60492-0173-02 | 60492-0173 |
| 60492-0173-2 | 60492-0173 |
| 60492-173-02 | 60492-173 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CNJ-016 | VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | Emergent BioSolutions Canada Inc. | a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 60492-0173-2 60492-0173 60492017302 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.